PDIR Inhibitors
PDIR inhibitors, short for Proline/Aspartate/Arginine-rich (PDIR) inhibitors, represent a class of compounds that exert their effects by modulating the activity of proteins rich in proline, aspartate, and arginine residues. These inhibitors play a crucial role in the realm of molecular biology and biochemical research, where precise control over cellular processes is paramount. The intricate regulation of cellular functions often involves the dynamic interplay of various proteins and their post-translational modifications. PDIR inhibitors, by selectively targeting proteins rich in proline, aspartate, and arginine, contribute to the nuanced orchestration of cellular events.
PDIR inhibitors are designed to interact with the specific amino acid residues in the target proteins, thereby influencing their conformation and function. This targeted interference allows researchers to dissect and elucidate intricate signaling pathways, gene expression patterns, and protein-protein interactions within the cellular milieu. The ability of PDIR inhibitors to modulate the activity of proteins rich in proline, aspartate, and arginine positions them as invaluable tools in unraveling the complexities of cellular regulation. By understanding the molecular mechanisms influenced by PDIR inhibitors, researchers can glean insights into fundamental cellular processes, paving the way for advancements in various fields, such as cell biology and biochemistry.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibits ER to Golgi transport, which can increase ER stress and potentially disrupt PDIA5 function. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Blocks N-linked glycosylation, heightens ER stress, and may indirectly affect PDIA5's substrate availability. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca²⁺ ATPase (SERCA), leading to increased ER stress and possible indirect inhibition of PDIA5. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
Binds to vicinal dithiols and may disrupt PDIA5's catalytic site, inhibiting its isomerase activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can increase the level of misfolded proteins in ER, potentially overloading PDIA5's functional capacity. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $114.00 $203.00 $354.00 $697.00 $1363.00 $5836.00 | 12 | |
Inhibits ER-associated degradation (ERAD), likely increasing the load on PDIA5 by accumulating misfolded proteins. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
Irreversibly modifies cysteine residues and could impede the catalytic cycle of PDIA5 by modifying its active site. | ||||||
4-Phenylbutyric acid | 1821-12-1 | sc-232961 sc-232961A sc-232961B | 25 g 100 g 500 g | $53.00 $136.00 $418.00 | 10 | |
A chemical chaperone that reduces ER stress, which may indirectly lessen the functional demand on PDIA5. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Specific inhibitor of phosphatases that dephosphorylate eIF2α, leading to reduced general protein synthesis and indirect effects on PDIA5 activity. | ||||||
ISRIB | 1597403-47-8 | sc-488404 | 10 mg | $300.00 | 1 | |
Reverses the effects of eIF2α phosphorylation, likely impacting PDIA5 by modulating protein folding demand in ER. | ||||||